Martin Shkreli’s notorious mixture of contempt and bemusementwas on full-display at a Congressional hearing over drug prices onThursday.

The controversial pharmaceutical executive attended the hearingto which he had been subpoenaed but said almostnothing in response to questions about his business practices.Because Shkreli is facing criminal charges of defrauding investors,he invoked his Fifth Amendment right againstself-incrimination.

Those charges are not related to his leadership of TuringPharmaceuticals, the firm that is one of the subjects of a pricegouging investigation by Congress, but it was apparently relatedenough that his attorney advised him to remain silent and Congresshas not sought any legal remedy yet to force him to talk.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Broker Regulation
Consumer Driven Health Care